Sign in

NCT07352176Not yet recruiting

Study on the Effectiveness and Safety of CLE Combined With Cryobiopsy for Diagnosis of Pulmonary Lesions

Study on the Effectiveness and Safety of Confocal Laser Endomicroscopy Combined With Ultrafine Cryoprobe for Biopsy Diagnosis of Pulmonary Lesions

Source: ClinicalTrials.gov · Last updated 20 Jan 2026

Brief summary (registry, in English)

Forty subjects meeting the inclusion and exclusion criteria were recruited at a single center and signed informed consent forms. Among them, 20 patients in the diffuse group and 20 patients in the localized group were randomly assigned to the conventional radial endobronchial ultrasound combined with cryobiopsy group (conventional group) and the confocal laser endomicroscopy combined with cryobiopsy group (combined group). During the operation, the operator manipulated the bronchoscope to reach the lesion. After confirming the arrival at the lesion using radial endobronchial ultrasound/confocal laser endomicroscopy, cryobiopsy was performed, and the size of the sample was recorded. CBCT scanning was conducted after cryobiopsy. If there was no hole-in-lesion image, cryobiopsy was performed again under CBCT guidance. CBCT scanning was performed after biopsy to determine whether there were any adverse events.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
11 Jan 2026
Start date
1 Feb 2026
Primary completion date
31 Dec 2026
Lead sponsor
Guangzhou Medical University
Diseases
Lung cancer
NCT number
NCT07352176

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Feb 2026 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who cannot discontinue therapeutic anticoagulants within an appropriate time interval before surgery;

Other illness

  • Patients with uncorrectable coagulation disorders;
  • Patients with severe liver or kidney dysfunction, mental illness, etc.;

Other

  • Patients with contraindications to anesthesia or bronchoscopy;
  • Pregnant or lactating patients;
  • Patients without a clear histological or clinical diagnosis;
  • Subjects deemed unsuitable for participation in this study by the investigator.

Who the study is looking for

  • Patients over 18 years old with lung lesions indicated by chest CT;
  • Preoperative CT indicates that the lung lesion to be biopsied has a bronchus leading to it;
  • Able to understand and voluntarily sign the written informed consent form. -

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510163
Coordinator of this site? Confirm its status
GuangzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.